Poster'35:'' RITUXIMABIBENDAMUSTINE:' STILL' AN' OPTION' FOR' ELDERLY' PATIENTS'
WITH'CHRONIC'LYMPHOCYTIC'LEUKEMIA?'
! Francisca&Miranda,&Ana&Jorge,&Celina&Afonso&
&
Poster'36:'' LYMPHOMATOID' GRANULOMATOSIS' MIMICKING' PSEUDOSARCOIDOTIC'
GRANULOMATOSIS':'A'CASE'REPORT'
! Aznag&Mohamed&Amine,&Raissi&Abderrahim&
&
Poster'37:'' PHASE'2'MULTICENTER'STUDY'OF'TAZEMETOSTAT,'AN'EZH2'INHIBITOR,'IN'
PATIENTS'WITH'RELAPSED'OR'REFRACTORY'FOLLICULAR'LYMPHOMA'
! Franck& Morschhauser,& Hervé& Tilly,& Aristeidis& Chaidos,& Tycel& Phillips,& Vincent& Rigbrag,&
Philip& Campbell,& Gandhi& Laurent& Damaj,& Wojciech& Jurczak,& Pamela& McKay,& Stephen&
Opat,&John&Radford,&Jennifer&Whalen,&Anand&Rajarethinam,&Deyaa&Adib,&Gilles&Salles&
&
Poster'38:'' LIQUID' BIOPSYIBASED' MONITORING' OF' EZH2' MUTATIONS' IN' FOLLICULAR'
LYMPHOMA:'IMPLICATIONS'FOR'NONIINVASIVE'DISEASE'MONITORING'AND'
TARGETED'THERAPY'
! Ákos& Nagy,& Bence& Bátai,& Alexandra& Balogh,& Illés& Sarolta,& Gábor& Mikala,& Noémi& Nagy,&
Laura&Kiss,&Lili&Kotmayer,&András&Matolcsy,&Donát&Alpár,&Tamás&Masszi,&András&Masszi,&
Csaba&Bödör&
&
Poster'39:'' BEAMILIKE' MYELOABLATIVE' REGIMEN' CONSISTED' OF' ETOPOSIDE,' ARAI
CYTARABINE,' AND' MELPHALAN' (EAM' PROTOCOL)' COULD' BE' USE' AS' A'
REASONABLE' CONDITIONING' CHEMOTHERAPY' FOR' AUTOLOGOUS'
TRANSPLANT'IN'A'PATIENT'WITH'RELAPSED'HODGKIN'LYMPHOMA'
! Ridho&M.&Naibaho,&Eko&A.&Pangarsa,&Catharina&Suharti&
&
Poster'40:'' INTRAVITREAL' METHOTREXATE' IN' THE' THERAPEUTIC' MANAGEMENT' OF'
REFRACTORY' EXTRANODAL' NATURAL' KILLER' (NK)/TICELL' LYMPHOMA,'
NASAL'TYPE,'WITH'OCULAR'INVOLVEMENT'
! Dulcelena&Neves,&Ricardo&Ferreira,&Lenka&Ruzickova,&Marília&Gomes,&Letícia&Ribeiro&
&
Poster'41:'' PRIMARY' REFRACTORY' DLBCL’S' RESULTS' AFTER' AUTOLOGOUS' STEM' CELL'
TRANSPLANTATION'
! Ana& Carolina& Oliver,& Pablo& Muxi,& Eloisa& Riva,& Sebastian& Galeano,& Silvia& Pierri,& Ada&
Caneiro,&Laura&Bello,&Regis&Gai,&Andrew&Miller&
&
Poster'42:'' CASE' REPORT:' GRANULOMATOUS' UVEITIS' AS' PRESENTATION' OF'
INTRAOCULAR' DIFFUSE' LARGE' BICELL' LYMPHOMA' –' A' DIAGNOSTIC'
CHALLENGE'
! Rita&S.&Gomes,&Sara&Duarte,&Marília&Gomes,&José&Carda,&Letícia&Ribeiro&
&
Poster'43:'' MANTLE' CELL' LYMPHOMA' OF' MUCOSAIASSOCIATED' TISSUE:' AN'
ILLUSTRATIVE'CLINICAL'CASE'
! Ana&Silva&Martins,&Daniela&Alves,&Conceição&Lopes,&João&Raposo&
&
Poster'44:'' LYMPHOMA' AND' COMMON' VARIABLE' IMMUNODEFICIENCY' I' A' CASE'
REPORT'
! Cátia&Sol&Reis,&Ana&Carneiro,&Manuel&Sobrinho&Simões,&Elsa&Fonseca,&Fernanda&Trigo&
SCIENTIFIC PROGRAMME
SESSION I
HODGKIN’S DISEASE
DEBATE I
IS THERE STILL A ROLE
FOR COMBINED MODALITY
THERAPY FOR EARLY
STAGE CHL?
SESSION II
T-CELL LYMPHOMA
ROUNDTABLE I
FUTURE DIRECTIONS IN
T-CELL LYMPHOMA
SESSION III
FOLLICULAR LYMPHOMA
DEBATE II
CAN WE AVOID
CHEMOTHERAPY IN
THE MANAGEMENT OF
FOLLICULAR LYMPHOMA?
SESSION IV
RARE LYMPHOMAS –
MARGINAL ZONE
LYMPHOMA AND
WALDENSTRÖM M
ACROGLOBULINEMIA
ROUNDTABLE II – WHERE
TO GO IN RARE B-CELL
LYMPHOMAS
SESSION V
MANTLE CELL LYMPHOMA
SESSION VI
DIFFUSE LARGE B-CELL
LYMPHOMA
DEBATE III
DO WE STILL NEED ASCT
IN MCL?
SESSION VII
NOVEL THER APEUTIC
CONCEPTS IN B-CELL
LYMPHOMAS
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
FOR A POSTER
PRESENTATION
DISCLOSURES